Formoterol PCD Pharma Franchise Company
Cafoli Lifecare offers a comprehensive Formoterol PCD pharma franchise built on 24 formulations spanning inhalers, rota caps, sprays, capsules and tablets, all manufactured at WHO-GMP certified facilities. This gives franchise partners a core respiratory bronchodilator line for chest physicians and pulmonologists.
What is Formoterol?
Formoterol is a long-acting beta-2 adrenergic agonist (LABA) with a rapid onset of action. It relaxes airway smooth muscle to relieve and prevent bronchospasm, and its 12-hour duration makes it suitable for maintenance therapy, usually in combination with an inhaled corticosteroid. Read its profile on MedlinePlus.
Therapeutic Applications
Formoterol is prescribed for the long-term maintenance of asthma and COPD and for the prevention of exercise-induced bronchospasm. Because of its fast onset it is also used in ICS-formoterol maintenance-and-reliever regimens. Prescribers include pulmonologists, chest physicians, paediatricians and consultant physicians.
Why Formoterol is a High-Potential Molecule for Distributors
Formoterol is a workhorse of modern inhaler therapy — it appears in the ICS-LABA combination inhalers that form the backbone of asthma and COPD management, both chronic, lifelong conditions. Its unique fast-onset-plus-long-duration profile keeps it central to preferred maintenance-and-reliever protocols. With 24 device and combination formulations, a distributor can serve every respiratory prescriber need from one high-repeat molecule.
Why Choose Cafoli Lifecare
Cafoli Lifecare provides territory-wise monopoly rights, WHO-GMP certified manufacturing, DCGI-approved formulations, complete promotional inputs and the backing of 1000+ franchise partners across India.
References
- MedlinePlus: Formoterol
- PubChem: Formoterol
Our formulations of Formoterol find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to: